Hypoxia-inducible factors in physiology and medicine
BPC-157 could calm the immune system when its overly active, potentially relieving symptoms related to chronic inflammation or autoimmune reactions
Notably, all patients had previously been treated with pentosan polysulfate, which is currently the only FDA approved treatment for interstitial cystitis, and had not responded
We have developed trans-cranial vascular doppler blood-brain barrier ultrasound imaging analysis, personalized IV infusions, therapeutic nerve blocks, cervicogenic headache treatments, spine interventions, nutrition strategies, peptide therapies, specialized lab analysis, stem cell therapies, regenerative interventions, prolotherapy, hydrodissection of nerve entrapments, hormone optimization for the syndrome of cognitive impairment, cognitive decline, brain fog, headaches and/or neck pain, plus there are also additional therapies under investigation like certain peptides (possibly including BPC-157, Semax, TB-500, Epithalon, P021, NVG-291, BIIB080, or others) and Sirtuin modulators listed above, as well as shockwave therapy, myofascial release, and image-guided nerve releases and interventional procedures that can relieve pain, release spasms, and increase lymphatic flow and treatment of underlying neuropathologies
Sleep and stress have been addressed
